August 27, 2016 3:16 PM ET

Pharmaceuticals

Company Overview of Astellas Pharma, Inc.

Executive Profile

Sef P. Kurstjens M.D., Ph.D.

Chief Medical Officer and President of Global Development, Astellas Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Sef P. Kurstjens, M.D., Ph.D. serves as Chief Medical Officer at Astellas Pharma Inc. Dr. Kurstjens has been the President of Astellas Pharma Global Development, Inc. since October 2013. Dr. Kurstjens serves as Chief Medical Officer of Astellas Pharma, Inc. Dr. Kurstjens served as the President and the Chief Executive Officer at Agensys, Inc. since November 2010. Dr. Kurstjens served as the Senior Vice President, Chief Medical Officer and Head, Global Drug Development ...

Corporate Headquarters

2-5-1, Nihonbashi-Honcho
Tokyo, -- 103-8411

Japan

Phone: 81 3 3244 3000
Fax: --

Board Members Memberships

2011-Present
Director

Education

Unknown/Other Education
Wits Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$1.0M
José E. Almeida Chairman and Chief Executive Officer
Baxter International Inc.
$231.5K
Joseph C. Papa Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
--
Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
--
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director, Member of Innovation & Development Committee and Member of Securities & Market Disclosure Committee
CSL Ltd.
$5.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Astellas Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.